Stockreport

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum [Yahoo! Finance]

Entero Therapeutics Inc.  (ENTO) 
PDF biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, [Read more]